Please login to the form below

Not currently logged in
Email:
Password:

Reig Jofre and LeanBio launch Syna Therapeutics

The new company will focus on the development of biosimilars

Reig JofrePharmaceutical group Reig Jofre has entered into a strategic alliance with LeanBio, a four-year-old biotech company, to launch a new company focused on the development of biosimilars and ‘innovative’ molecules.

Much like its parent companies, Syna Therapeutics will be headquartered in Barcelona, Spain, where LeanBio’s founder Dr Andreu Soldevila will take the helm of the new business while Gabriel Roig becomes president of the board of directors.

Hoping to tap into a global biosimilar market of around €1,000m, Syna Therapeutics’ expertise will comprise of LeanBio’s biological development experience and Reig Jofre’s capability in formulation, stabilisation and pharmaceutical development of biological and injectable products.

Dr Soldevila said: “The development of a biosimilar is highly complex and one of the most important technological challenges of recent years.

“Bringing patients closer to biological treatments in a more sustainable way for national health systems means in addition a great social impact in a huge market.”

Syna Therapeutics will have to finance €9m to carry out the early stages of development, with the founding partners both contributing the initial capital estimated at €2m.

The new company has said it will also consider the entry of new financial or industrial commercial partners to support clinical development in its final stages.

Article by
Gemma Jones

26th March 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Genetic Digital

Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...

Latest intelligence

Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....
Hybrid working: Insights and tips for success
Porterhouse Medical has thrived by embracing a hybrid approach to work. Our article looks at hybrid working and provides some tips for success...